Skip to main content

Nasdaq IPOs

Is the IPO market the pathway out of the forest?

6 years 5 months ago
There is no better beacon of light for a path out of the tangled forest created by the Covid-19 virus than the ingenuity of the American people. It’s expressed in businesses large and small quickly transforming themselves into producers of PPE and the overnight migration of
Renaissance Capital

Oncology biotech ORIC Pharmaceuticals sets terms for $75 million IPO

6 years 5 months ago
ORIC Pharmaceuticals, a Phase 1 biotech developing small molecule therapies for treatment-resistant cancers, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16. At
Renaissance Capital

US IPO Week Ahead: Another quiet week for the IPO market

6 years 5 months ago
No IPOs are scheduled for the week ahead, though pipeline activity indicates that some may be on the way. Three out of the four IPOs since the second week of March have been biotechs, the sole exception being Chinese AR software company Wimi Hologram Cloud (WIMI). Oncology biotec
Renaissance Capital

US IPO Weekly Recap: 2 new filings keep the IPO market moving

6 years 5 months ago
There were no IPOs this past week, but initial filings from a biotech and a Chinese issuer are keeping the IPO market moving. After another strong week, the IPO Index is now up about 35% from its March lows. As we pointed out in our 1Q20 IPO Review, the first IPOs to emerge from
Renaissance Capital

A Longer View of IPO Fraud and Financial Restatements

6 years 5 months ago
In early April, a short seller accused Chinese coffee chain Luckin (LK) of massively overstating revenues. A day later Chinese education provider TAL reported a non-material overstatement of revenues by an errant employee. Are these two instances leading indicators of financ
Renaissance Capital
Checked
17 minutes 57 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed